Litigation

Recent Posts

Former Acting Chief Counsel Of FDA, Jeffrey M. Senger, Joins Sidley Austin LLP
Posted on 10 Aug 2010 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - Sidley Austin LLP has announced that Jeffrey M. Senger, former acting chief counsel and Deputy Chief Counsel of the Food and Drug Administration, has joined Sidley as a partner in the global food, drug and medical device regulatory... Read More

Russell Budd Announces Opening Of Baron & Budd P.C. Office In Miami
Posted on 10 Aug 2010 by LexisNexis Litigation Resource Community Staff

MIAMI - Russell Budd has announced the opening of plaintiff's law firm Baron & Budd, P.C. 's new office in Miami. The new office will offer its services to individuals and businesses with environmental issues as well as those victimized... Read More

Drug Czar: California Pot Law Could Spark Lawsuit
Posted on 20 Oct 2010 by LexisNexis Litigation Resource Community Staff

SAN FRANCISCO - (AP) Federal officials haven't ruled out taking legal action if California voters approve a ballot initiative that would legalize recreational marijuana use in the state, President Barack Obama's drug czar said Wednesday. In a... Read More

Supreme Court: Generic Drug Makers Not Liable For Warnings
Posted on 24 Jun 2011 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - (AP) The Supreme Court on Thursday ruled that makers of generic drugs cannot be sued for failing to warn consumers of the possible side effects of their products if they copy the exact warnings on the brand-name equivalents of the medicines... Read More

Amylin Sues Eli Lilly Over Diabetes Drug Development Deal
Posted on 17 May 2011 by LexisNexis Litigation Resource Community Staff

INDIANAPOLIS - (AP) Amylin Pharmaceuticals Inc. said Monday it filed a lawsuit against Eli Lilly and Co., accusing the larger drugmaker of breaking their commercialization deal for diabetes drugs by teaming with the German company Boehringer Ingelheim... Read More

Star Magazine Apologizes, Settles Katie Holmes Lawsuit
Posted on 1 May 2011 by LexisNexis Litigation Resource Community Staff

LOS ANGELES - (AP) Katie Holmes has settled her lawsuit with the publishers of Star magazine over a cover story that insinuated she was a drug addict. The magazine published an apology to the actress Wednesday on the cover and inside its May 9 issue,... Read More

Glaxo Settles Bad Drug Claim For More Than $40 Million
Posted on 24 Jun 2011 by LexisNexis Litigation Resource Community Staff

PROVIDENCE, R.I. - (AP) The American subsidiary of a major British drug maker, GlaxoSmithKline LLC, has agreed to pay more than $40 million to 37 states and Washington, D.C., to settle complaints alleging manufacturing process issues at a now-shuttered... Read More

Supreme Court Questions Limits On Use Of Prescription Data
Posted on 27 Apr 2011 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - (AP) The Supreme Court cast doubt Tuesday on efforts by states to limit drug manufacturers' use of information about the prescription drugs that doctors like to prescribe. The court took up a dispute between the state of Vermont... Read More

California Claims Drug Giant Bribed Doctors To Prescribe
Posted on 19 Mar 2011 by LexisNexis Litigation Resource Community Staff

LOS ANGELES - (AP) California has joined a whistleblower lawsuit that claims Bristol-Myers Squibb Co. bribed doctors to prescribe its drugs, costing insurers perhaps millions of dollars in the largest alleged health care fraud case ever handled by the... Read More

AstraZeneca Pays $198M To Settle Seroquel Lawsuits
Posted on 9 Aug 2010 by LexisNexis Litigation Resource Community Staff

LONDON - (AP) AstraZeneca PLC says it has paid around $198 million to settle U.S. lawsuits over its antipsychotic drug Seroquel. Full version available to lexis.com subscriber . Read More

Eli Lilly Loses Patent Lawsuit For Drug Strattera
Posted on 13 Aug 2010 by LexisNexis Litigation Resource Community Staff

INDIANAPOLIS - (AP) Eli Lilly & Co. on Thursday lowered its revenue outlook for the year after it lost a patent lawsuit over its attention deficit hyperactivity drug Strattera. The U.S. District Court for the District of New Jersey ruled against the... Read More

Citing Liver Damage, Pfizer Withdraws Thelin
Posted on 10 Dec 2010 by LexisNexis Litigation Resource Community Staff

NEW YORK - (AP) Pfizer Inc. said Friday it is pulling its blood pressure drug Thelin off the market and stopping all clinical trials because the drug can cause fatal liver damage . Thelin is sold in the European Union, Canada, and Australia as an oral... Read More

Novartis Wins Defense Verdict In Zometa Jaw Injury Trial
Posted on 26 May 2011 by Tom Moylan

BROOKLYN, N.Y. (Mealey's) A New York federal jury in the first federal Zometa trial found May 25 that the plaintiff did not prove by a preponderance of evidence that the Novartis Pharmaceuticals Corp. drug caused a decedent's osteonecrosis of... Read More

D.C. Circuit Says FDA Can Regulate Stem Cell Drugs; Company Properly Enjoined
Posted on 4 Feb 2014 by Tom Moylan

WASHINGTON, D.C. — The District of Columbia Circuit U.S. Court of Appeals on Feb. 4 said the federal government can regulate a company that cultures stem cells for injection in the donor patient and said a lower court did not err in permanently... Read More

Pennsylvania State Court Jury Awards Plaintiff $2 Million In Actos Bladder Cancer Case
Posted on 6 Oct 2014 by Tom Moylan

PHILADELPHIA — (Mealey’s) A Pennsylvania state court jury on Oct. 3 awarded an Actos bladder cancer patient $2.05 million in economic and noneconomic damages but declined to award punitive damages ( Frances Wisniewski v. Takeda Pharmaceuticals... Read More